A comprehensive view of Debut Biotechnology Inc.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Bioeconomy Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

CosmeticsDesign's January roundup: L'Oreal-backed Debut launches three products addressing inflammation; Kim Kardashian relaunches cosmetics range under SKKN​; Space NK and Lush hit by cyber attacks; Eurazeo invests in fragrance brand Ex Nihilo

Biotech company Debut will expand into fragrance category following latest Series B funding round, led by L'Oreal, reaching US$40M; Debut will leverage proprietary biomanufacturing platform to develop bio-identical and novel fragrance molecules

L'Oreal's investment in Debut will support its Bio2Consumer database and novel cosmetic ingredients; its hybrid cell-free technology can make high-performing bioactive ingredients that are not possible with fermentation, chemical synthesis or cultivation

L'Oreal venture capital fund BOLD leads US$34M funding round for startup Debut, a maker of ingredients for the beauty industry using synthetic biology; Debut's Bio2Consumer platform spans ingredient discovery, biofermentation, formulation, clinical trials

DIC and Debut launch joint business development in the area of polyphenols for cosmetics, nutrition industries using innovative biotechnology; first step includes construction of biomanufacturing facility in the US in 2023

Ask us about our Bioeconomy market view

Trending Chart

Interactive chart with headline count